Adrenal cortex mitochondrial steroidogenic enzyme systems

The adrenal cortex mitochondrial steroidogenic enzyme systems are a specialized group of enzymes and electron transport proteins located in the inner mitochondrial membrane of adrenocortical cells, primarily responsible for the biosynthesis of steroid hormones from cholesterol (NIH, 2021; ResearchGate, 2022). This system includes key cytochrome P450 enzymes such as CYP11A1 (cholesterol side-chain cleavage enzyme), CYP11B1 (11β-hydroxylase), and CYP11B2 (aldosterone synthase), which catalyze the rate-limiting and final steps of glucocorticoid and mineralocorticoid production (NIH, 2015; NIH, 2023). These enzymes rely on the electron-providing proteins adrenodoxin (FDX1) and adrenodoxin reductase (FDXR) to function (NIH, 2023). Dysregulation or overactivity of these enzymes leads to conditions such as Cushing's syndrome, primary aldosteronism, and adrenocortical carcinoma (NIH, 2015; NIH, 2023). Pharmacological agents like osilodrostat, metyrapone, and mitotane target these systems to inhibit hormone overproduction or induce adrenal cell death (Patsnap, 2024; NIH, 2023). Clinical management of these targets requires careful monitoring of hormone levels and potential side effects like adrenal insufficiency and electrolyte imbalances (NIH, 2023; NIH, 2024).

Other names

Mitochondrial steroidogenic enzymesAdrenal mitochondrial P450 systemAdrenal steroidogenesis systemMitochondrial steroidogenic pathwayAdrenal mitochondrial enzyme system

Inhibition of mitochondrial cytochrome P450 enzymes (CYP11B1, CYP11B2, CYP11A1) and disruption of mitochondrial membrane integrity and respiratory chain function (Patsnap, 2024; NIH, 2023).